The influence of epstein-barr virus reactivation in patients with graves' disease

Viral Immunology

Volumn 24, Issue 2, 2011, Pages 143-149

  Nagata, Keiko ^a,b   Fukata, Shuji ^c   Kanai, Kyosuke ^a   Satoh, Yukio ^a   Segawa, Takaya ^a   Kuwamoto, Satoshi ^b   Sugihara, Hirotsugu ^b   Kato, Masako ^b   Murakami, Ichiro ^b   Hayashi, Kazuhiko ^b   Sairenji, Takeshi ^a  

^a Division of Biosignaling   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIBODY; EPSTEIN BARR VIRUS SMALL RNA 1; IMMUNOGLOBULIN E; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IN SITU HYBRIDIZATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; NONHUMAN; PROTEIN BLOOD LEVEL; RADIORECEPTOR ASSAY; THYROID GLAND; VIRUS REACTIVATION;

ADULT; ANTIBODIES, VIRAL; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; GRAVES DISEASE; HUMANS; IMMUNOGLOBULIN E; MIDDLE AGED; RECEPTORS, THYROTROPIN; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 79953253665     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0072     Document Type: Article

References (34)

1. Amino N, Hidaka Y, Takano T, Izumi Y, Tatsumi KI, and Nakata Y: Association of seasonal allergic rhinitis is high in Graves' disease and low in painless thyroiditis. Thyroid 2003;13:811-814 (Pubitemid 37070160)
2. Ascherio A, Munger KL, Lennette ET, et al.: Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001;286:3083-3088. (Pubitemid 34016522)
3. Assouline J, and Major EO: Human fetal Schwann cells support JC virus multiplication. J Virol 1991;65:1002-1006.
4. Berkun Y, Zandman-Goddard G, Barzilai O, et al.: Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009;18:1129-1135.
5. Cepok S, Zhou D, Srivastava R, et al.: Identification of Ep-stein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005;115:1352-1360. (Pubitemid 40629055)
6. Cho MS, Milman G, and Hayward SD: A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48-to 50-kilodalton nuclear protein. J Virol 1985;56:860-866. (Pubitemid 16211824)
7. Davies P, and Larsen T: Thyrotoxicosis. In: Williams Textbook of Endocrinology, 11th ed. (Kronenberg HM, Melmed S, Po-lonsky KS, and Larsen PR, eds.). Saunders, Philadelphia, 2007, pp. 333-376.
8. Fan JL, Desai RK, Dallas JS, Wagle NM, Seetharamaiah GS, and Prabhakar BS: High frequency of B cells capable of producing anti-thyrotropin receptor antibodies in patients with Graves' disease. Clin Immunol Immunopathol 1994; 71:69-74. (Pubitemid 24126601)
9. Farrell RA, Antony D, Wall GR, et al.: Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 2009;73:32-38.
10. Henle G, Henle W, and Klein G: Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. Int J Cancer 1971;8:272-282.
11. Hidaka Y, Amino N, Iwatani Y, Itoh E, Matsunaga M, and Tamaki H: Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease. J Clin Endocrinol Metab 1993;77:1667-1670. (Pubitemid 24000932)
12. Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, and Liaw YF: Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospec-tive controlled study. Clin Endocrinol 1999;50:503-509.
13. Jabara HH, Schneider LC, Shapira SK, et al.: Induction of germ-line and mature Cε transcripts in human B cells stim-ulated with rIL-4 and EBV. J Immunol 1990;145:3468-3473.
14. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Leh-man TJ, and Harley JB: An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019-3026. (Pubitemid 28022839)
15. Kieff ED, and Rickinson AB: Epstein-Barr virus and its replication. In: Fields Virology, 5th ed. (Knipe DM, and Howley PM, eds.). Lippincott Williams & Wilkins, Philadelphia, 2006, pp. 2603-2654.
16. Komiya I, Yamada T, Sato A, Kouki T, Nishimori T, and Takasu N: Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13. J Clin Endocrinol Metab 2001;86:3540-3544. (Pubitemid 32755941)
17. Lunemann JD, Edwards N, Murano PA, Hayashi S, Cohen JI, Munz C, and Martin R Increased frequency and broad-ened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006;129:1493-1506. (Pubitemid 43999382)
18. Lunemann JD, Jelcic I, Roberts S, Lutterotti A, Tackenberg B, Martin R, and Munz C: EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 2008;205:1763-1773.
19. McClain MT, Heinlein LD, Dennis GJ, Roebuck J, Harley JB, and James JA: Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2005;11:85-89. (Pubitemid 40215842)
20. Nagata Y, Inoue H, Yamada K, et al.: Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients. Immunology 2004;111:223-229. (Pubitemid 38177952)
21. Pearson GR, Vroman B, Chase B, Sculley T, Hummel M, and Kieff E: Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J Virol 1983;47:193-201. (Pubitemid 13107074)
22. Pender MP: Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection. Autoimunity Rev 2009;8:563-568.
23. Rickinson AB, and Kieff E: Epstein-Barr virus. In: Fields Virology, 5th ed. (Knipe DM, and Howley PM, eds.). Lip-pincott Williams & Wilkins, Philadelphia, 2006, pp. 2655-2700.
24. Shewring G, and Smith BR: An improved radioreceptor as-say for TSH receptor antibodies. Clin Endocrinol 1982; 17:409-417. (Pubitemid 12064250)
25. Sundstrom P, Juto P, Wadell G, et al.: An altered immune response to Epstein-Barr virus in multiple sclerosis: a pro-spective study. Neurology 2004;62:2277-2282. (Pubitemid 38787787)
26. Thomas D, Liakos V, Michou V, Kapranos N, Kaltsas G, Tsilivakos V, and Tsatsoulis A: Detection of herpes virus DNA in post-operative thyroid tissue specimens of patients with autoimmune thyroid disease. Exp Clin Endocrinol Diabetes 2008;116:35-39. (Pubitemid 351270906)
27. Thyphronitis G, Tsokos GC, June CH, Levine AD, and Fin-kelman F: IgE secretion by Epstein-Barr virus-infected pu-rified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon γ. Proc Natl Acad Sci USA 1989;86:5580-5584 (Pubitemid 19185588)
28. Tomer Y, and Menconi F: Interferon induced thyroiditis. Best practice & research. Clin Endocrinol Metab 2009;23:703-712.
29. Uchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwi-chit W, Raab-Traub N, and Kikutani H: Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte re-sponses. Science 1999;286:300-303. (Pubitemid 29484694)
30. Vento S, Guella L, Mirandola F, et al.: Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 1995;346:608-609.
31. von Herrath MG, Fujinami RS, and Whitton L: Micro-organisms and autoimmunity: making the barren field fer-tile? Nature Rev 2003;1:151-157.
32. Wandinger K, Jabs W, Siekhaus A, et al.: Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000;55:178-184. (Pubitemid 30604615)
33. Yamada T, Sato A, Komiya I, Ito Y, Terao A, Eto S, and Tanaka Y: An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. J Clin Endocrinol Metab 2000;85:2775-2778. (Pubitemid 32269150)
34. Zandman-Goddard G, Berkun Y, Barzilai O, et al.: Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann NY Acad Sci 2009;1173:658-663.